Status:

COMPLETED

Genetic Analysis of African-Americans With High Blood Pressure

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Hypertension

Eligibility:

All Genders

21+ years

Brief Summary

The purpose of this study is to learn if kinase, a protein found in the heart, contributes to thickening of the heart muscle in people with high blood pressure. A protein called myosin causes the hea...

Detailed Description

Genetic and in vitro mechanical studies in our laboratory have suggested that the perturbations in the phosphorylation of the cardiac myosin regulatory light chain (RLC) can modulate cardiac function ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Inclusion Criteria (Main Cohort):
  • Afro-American patients with a history of hypertension
  • Age greater than or equal to 21 years old
  • Presence of the kinase allele (homo or heterozygous)
  • Ability to give informed consent.
  • Inclusion Criteria (Myopathy Cohort):
  • All of the above as well as:
  • Left ventricular ejection fraction of less than 35% by any imaging technique.
  • EXCLUSION CRITERIA
  • For subjects with Kinase Allele:
  • There will be no exclusion criteria. Patients will be evaluated even if they are only able to participate in part of the study.
  • For Subjects without the kinase allele and Myopathy Cohort:
  • History of myocardial infarction
  • History of significant valve disease
  • History of primary hyperthropic or infiltrative cardiomyopathy
  • History of rheumatic heart disease
  • Chronic atrial arrhythmia, bundle branch block intraventricular conduction defect or definite myocardial infarction on EKG
  • Inability to perform a metabolic stress test
  • Inability to perform a cMRI
  • Poor echocardiographic windows precluding accurate analysis

Exclusion

    Key Trial Info

    Start Date :

    October 5 1999

    Trial Type :

    OBSERVATIONAL

    End Date :

    December 10 2007

    Estimated Enrollment :

    1000 Patients enrolled

    Trial Details

    Trial ID

    NCT00353925

    Start Date

    October 5 1999

    End Date

    December 10 2007

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Maryland, Baltimore

    Baltimore, Maryland, United States, 21201-1595